Concepedia

Publication | Open Access

Intravitreal Autologous Bone Marrow CD34+ Cell Therapy for Ischemic and Degenerative Retinal Disorders: Preliminary Phase 1 Clinical Trial Findings

DOIFull Paper Access

185

Citations

19

References

2014

Year

S. S. Park, G. Bauer, Mehrdad Abedi, Suzanne Pontow, Athanasios Panorgias, Ravi S. Jonnal, Robert J. Zawadzki, John S. Werner, Jan A. Nolta
Investigative Ophthalmology & Visual Science

Abstract

Intravitreal autologous BM CD34+ cell therapy appears feasible and well tolerated in eyes with ischemic or degenerative retinal conditions and merits further exploration. (ClinicalTrials.gov number, NCT01736059.).

References

YearCitations

Page 1